Search

You searched for "neovascular"

1185 results found

A helping hand from Altomed

11 December 2025 | Company Profiles, Research & Development
Your training journey is important and Altomed is here to help you build skills with confidence. That’s why, for a short time only, we’re offering a Buy 2, Get 1 Free promotion on 4 SimulEYE models (see website for full...

Raphaél Ervinckx joins Glaukos

11 December 2025 | Recruitment & Personnel
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...
Journal of Glaucoma front cover image.

Clinical outcomes following intraluminal stent removal from the PAUL glaucoma implant

30 January 2026 | | EYE - Glaucoma
This single German centre retrospective cohort study included 70 eyes from 68 patients. Qualified and complete success rates (95% CI) were 92.9% and 55.7% after 1 year and 88.6% (81.4–95.7%) and 50% (37.1–62.9%) at the last follow-up time point for...
Ophthalmology journal front cover image.

Low-dose bimatoprost/timolol gel: a new fixed-combination option

3 February 2026 | | EYE - Glaucoma
This phase III international randomised trial evaluated the efficacy and safety of a new low concentration bimatoprost/timolol eye gel (bimatoprost 0.01%/timolol 0.1%). It was compared with the conventional higher-strength fixed combination eye drops (bimatoprost 0.03%/timolol 0.5%) in patients with open-angle...

What's trending Dec/Jan 2019

1 December 2018 | | EYE - Orbit, EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
The Eye News Twelve Days of Christmas On the first day of Christmas, my true love gave to me…A #RyderCup globe injury An unfortunate spectator was hit in the eye by a wayward golf ball during the Ryder Cup, and...

DR-NET National DR Workshop in Tanzania: Policy, training and technology

4 August 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...

Sustainability in eyecare: Are virtual clinics the way forward in the diagnosis and monitoring of retinal disease?

2 August 2021 | | EYE - Vitreo-Retinal, EYE - General
Virtual clinics can be used successfully in screening and management of ocular conditions such as diabetic retinopathy, retinopathy of prematurity and age-related macular degeneration. Virtual clinics should be a considered as a more clinically appropriate modality of consultation, diagnosis and...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Innovative 3D printing could revolutionise treatment for cataracts and other eye conditions

28 May 2024 | research, breakthrough, cataract, refractive, IOL, intraocular, lens, 3D, printing
University of East Anglia researchers have made a significant breakthrough in ocular device technology with the introduction of a novel resin for 3D printing intraocular devices. This innovation has potential to enhance the manufacture of eye implants universally used in cataract and refractive surgeries.

Managing cataract surgery in a patient with diabetic maculopathy

1 August 2016 | | EYE - Cataract, EYE - Refractive
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...

The results of the last survey Feb21

4 February 2021 | | EYE - Cataract, EYE - Refractive, EYE - General
Once again, I am grateful for the responses and read the results with interest. I am always surprised by the amount of practice variation I see. I fully accept there is art in what we do and there is no...

A single intravitreal bevacizumab in the treatment of breast carcinoma related choroidal metastasis

1 June 2015 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report Choroidal metastasis represents a common form of intraocular malignancies occurring in up to 10% of patients with systemic metastasis [1]. The most common primary sites of ocular metastasis are breast carcinoma in women and lung carcinoma in men,...